Fast-acting antidepressants trigger presynaptic BDNF release and structural plasticity at mouse mossy fiber-CA3 synapses

This study reveals that fast-acting antidepressants like ketamine and HNK rapidly induce presynaptic BDNF release from mossy fiber terminals via preNMDARs, triggering structural plasticity in CA3 synapses and challenging the prevailing view that antidepressant efficacy relies solely on postsynaptic BDNF signaling.

The Gist

The Big Picture: Fixing a Broken Garden

Imagine your brain is a vast, intricate garden. In people with depression, parts of this garden become overgrown with weeds, and the pathways between the plants (neurons) get blocked or withered. This makes it hard for the garden to communicate and grow.

For a long time, scientists knew that a special fertilizer called BDNF (Brain-Derived Neurotrophic Factor) helps this garden grow back. But they didn't know exactly how fast-acting antidepressants (like Ketamine) delivered this fertilizer so quickly—often working in hours rather than weeks.

This study discovered a secret delivery route that scientists had never seen before.

---

The Cast of Characters

1. The Gardeners (Neurons): Specifically, the "Dentate Granule Neurons" in the hippocampus (a memory center). Think of them as the master gardeners.
2. The Fertilizer (BDNF): The nutrient that helps new branches and leaves (synapses) grow.
3. The Delivery Trucks (Mossy Fiber Terminals): These are the specific "trucks" that carry the fertilizer. They are located at the very end of the gardener's arm (the axon), ready to drop off supplies.
4. The Receiving Station (CA3 Pyramidal Neurons): The plants that receive the fertilizer. They are the ones that need to grow new leaves (dendritic spines).
5. The Switch (NMDA Receptors): A control panel on the delivery trucks.
6. The Fast-Acting Meds (Ketamine & HNK): The new tools that flip the switch to start the delivery.

---

The Discovery: A Secret Backdoor Delivery

The Old Theory:
Previously, scientists thought antidepressants worked by telling the receiving station (the plant) to make its own fertilizer. It was like telling the plant, "Hey, you need to grow a new leaf, so please manufacture your own nutrients." This takes time.

The New Discovery:
This study found that Ketamine and its metabolite (HNK) don't wait for the plant to make fertilizer. Instead, they go straight to the delivery trucks (the presynaptic terminals) and hit the "Release" button immediately.

The Analogy:
Imagine a busy highway (the brain).

• Before: The traffic was stuck. The delivery trucks were parked, and the fertilizer was sitting in the warehouse.
• The Ketamine Effect: Ketamine doesn't just tell the warehouse to work harder. It jumps into the driver's seat of the delivery truck and hits the gas. Within minutes, the truck drives up to the receiving station and dumps the fertilizer right there.

The "How It Works" Mechanism

The researchers found two very specific rules for how this delivery happens:

1. The "Glue" vs. The "Engine":
   Usually, to make a truck move, you need fuel (electricity/ion flow). But here, Ketamine works differently. It turns on the "Glue" (the receptor) without needing the "Engine" (electricity).

   • Analogy: Imagine a doorbell that usually requires electricity to ring. Ketamine is like a person who physically pushes the button with their finger. The doorbell rings (the signal is sent), but no electricity was needed to make it happen. This allows the truck to release the fertilizer even when the usual electrical signals are quiet.

2. Two Different Keys for Two Different Meds:

   • Ketamine: It only needs the driver's side (presynaptic) switch to be flipped. It tells the truck to drop the load immediately.
   • HNK (The Metabolite): It needs both the driver's side switch and a signal from the passenger side (postsynaptic) to get the truck moving. It's a more complex handshake.

The Result: Rapid Growth

Once the fertilizer (BDNF) is dropped off, the receiving plants (CA3 neurons) go crazy with growth.

• The Visual: Imagine a dry, bare branch suddenly sprouting dozens of new, healthy leaves in just 30 minutes.
• The Science: The study showed that within 30 minutes of treatment, the number of "spines" (the little hooks where neurons connect) increased significantly. This creates new pathways for communication, effectively repairing the broken garden.

Why This Matters

1. Speed: This explains why these drugs work so fast. They aren't waiting for the brain to slowly build new connections; they are triggering an immediate "drop-off" of growth nutrients at the exact spot where they are needed.
2. New Targets: By realizing that the "delivery trucks" (presynaptic terminals) are the key, doctors might be able to design new drugs that target these specific trucks even more precisely, potentially with fewer side effects.
3. The "GluN3A" Clue: The study found that these trucks have a special type of lock (GluN3A receptors) that makes them sensitive to this specific type of delivery. This is a new clue for how to unlock the brain's healing potential.

Summary in One Sentence

This paper reveals that fast-acting antidepressants work by hijacking the brain's delivery trucks at the source, forcing them to instantly drop off growth nutrients (BDNF) to rebuild the brain's connections, rather than waiting for the brain to slowly manufacture them on its own.

Technical Summary

1. Problem Statement

Major Depressive Disorder (MDD) is linked to deficits in hippocampal synaptic plasticity, a process heavily dependent on Brain-Derived Neurotrophic Factor (BDNF). While fast-acting antidepressants like ketamine and its metabolite (2R,6R)-hydroxynorketamine (HNK) rapidly induce synaptic plasticity and behavioral improvement, the precise cellular mechanisms remain unclear.

• Current Gap: The prevailing hypothesis posits that antidepressant-induced BDNF release originates primarily from postsynaptic dendritic spines.
• Knowledge Deficit: It is unknown if presynaptic axonal terminals serve as a source of rapid BDNF release, which specific NMDA receptor (NMDAR) populations mediate this release, and how this relates to the rapid structural remodeling of synapses observed in MDD treatment.

2. Methodology

The study employed a multi-modal approach combining rodent models, advanced imaging, and genetic manipulation to dissect the source and mechanism of BDNF release.

• Models:
  • In Vitro: Primary dissociated rat hippocampal neurons (21 days in vitro).
  • In Vivo/Ex Vivo: Acute hippocampal slices from mice (including Grin1 conditional knockout lines and Thy1-eGFP mice).
• Genetic Tools:
  • Viral Vectors: AAV5-CaMKII-mCherry-cre and AAV-DJ-DIO-BDNF-pHluorin (BDNF-pH) were used for cell-type-specific manipulation.
  • Conditional Knockout: Grin1 (obligatory NMDAR subunit) was selectively deleted in Dentate Gyrus (DG) granule neurons (presynaptic) or CA3 pyramidal neurons (postsynaptic) to isolate receptor contributions.
• Imaging & Reporting:
  • BDNF-SEP/pHluorin: A pH-sensitive fluorescent reporter fused to BDNF was used to visualize real-time exocytosis. A drop in fluorescence indicates release into the acidic extracellular space.
  • Two-Photon Microscopy: Used to image BDNF release from mossy fiber terminals (MFTs) and structural changes in CA3 dendritic spines in acute slices.
  • Confocal Microscopy: Used for time-lapse imaging in dissociated cultures.
  • Immuno-electron Microscopy: Pre-embedding silver-intensified immunogold (SIG) labeling with anti-GluN3A antibodies to map NMDAR localization at the ultrastructural level.
• Pharmacology:
  • Application of Ketamine (1 µM in culture; 20 µM in slices) and HNK (10 nM in culture; 10 µM in slices).
  • Use of NMDAR antagonists: APV (competitive, blocks glutamate binding) and MK-801 (non-competitive, open-channel blocker) to distinguish between ion flux and metabotropic signaling.

3. Key Contributions

This study provides the first direct evidence that:

1. Presynaptic Origin: Fast-acting antidepressants trigger rapid BDNF release specifically from presynaptic mossy fiber terminals of DG granule neurons, not from postsynaptic dendritic spines.
2. Receptor Mechanism: This release is mediated by presynaptic NMDARs (preNMDARs) containing GluN3A subunits.
3. Signaling Mode: Ketamine-induced release relies on glutamate binding to preNMDARs but is independent of ion channel flux (metabotropic signaling), whereas HNK requires both pre- and postsynaptic NMDARs.
4. Structural Consequence: This presynaptic BDNF release drives rapid (within 30 minutes) increases in dendritic spine density in postsynaptic CA3 pyramidal neurons.

4. Key Results

• Rapid Presynaptic BDNF Release:

  • In rat hippocampal cultures, acute application of Ketamine (1 µM) and HNK (10 nM) evoked rapid BDNF exocytosis from mossy fiber terminals within minutes.
  • No release was detected from dendritic spines within the same timeframe.
  • Release was confirmed via immunocytochemistry (ZnT3 marker) and morphology (large boutons).

• Role of NMDARs and Ion Flux:

  • Localization: Electron microscopy confirmed high enrichment of GluN3A-containing NMDARs at presynaptic mossy fiber terminals compared to postsynaptic spines.
  • Mechanism:
    • APV (blocks glutamate binding) abolished Ketamine-evoked release.
    • MK-801 (blocks ion flux) did not prevent release.
    • Conclusion: Ketamine drives BDNF release via a metabotropic mechanism (ligand binding without ion flow) at preNMDARs.

• Genetic Dissection (DG vs. CA3):

  • Presynaptic (DG) Deletion: Conditional deletion of Grin1 in DG granule neurons abolished BDNF release induced by both Ketamine and HNK. This confirms preNMDARs are essential.
  • Postsynaptic (CA3) Deletion: Conditional deletion of Grin1 in CA3 pyramidal neurons:
    • Had no effect on Ketamine-evoked release.
    • Significantly reduced HNK-evoked release.
    • Conclusion: Ketamine acts solely via preNMDARs, while HNK requires a retrograde or circuit-level signal involving postsynaptic NMDARs.

• Structural Plasticity:

  • Treatment with Ketamine or HNK for 30 minutes resulted in a net increase in dendritic spine density on CA3 pyramidal neurons.
  • Remodeling was dynamic (spine gains and losses) but favored net growth, correlating temporally with the BDNF release burst.

5. Significance

• Paradigm Shift: Challenges the dogma that antidepressant efficacy is initiated solely by postsynaptic BDNF release. It identifies the presynaptic terminal as a critical, previously unrecognized source of rapid neurotrophin signaling.
• Mechanistic Insight: Reveals that metabotropic preNMDAR signaling (specifically GluN3A-containing receptors) is a key driver of rapid synaptic plasticity. This explains why open-channel blockers (like MK-801) might not fully replicate the effects of ketamine on BDNF release in this specific circuit.
• Therapeutic Implications:
  • Suggests that targeting presynaptic NMDARs or the specific GluN3A subunit could lead to novel, faster-acting antidepressants with fewer side effects.
  • Provides a cellular basis for the rapid structural remodeling (spinogenesis) required for the sustained efficacy of fast-acting antidepressants.
• Circuit Specificity: Highlights the unique role of the Mossy Fiber-CA3 pathway, a circuit rich in BDNF and preNMDARs, as a primary locus for the initiation of antidepressant responses.

In summary, the paper establishes a direct causal link between fast-acting antidepressants, presynaptic BDNF release via metabotropic preNMDARs, and rapid structural plasticity in the hippocampus, offering a refined molecular target for treating depression.